Paul Poommipanit is a Cardiology physician affiliated with Cleveland Clinic. OpenAlex indexes 159 publications with 768 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74%Beta blocker20.2%Metoprolol Succinate51%Metoprolol Tartrate25%Carvedilol19%Atenolol5%Part D<11 patientsStatin17.6%Atorvastatin Calcium78%Rosuvastatin Calcium16%Pravastatin Sodium4%Simvastatin2%Part D<11 patients+ 14 more classes in this area
Blood & clotting
20.9%P2Y12 inhibitor14.2%Clopidogrel87%Brilinta9%Prasugrel Hcl5%Part D<11 patientsFactor Xa inhibitor6.7%Eliquis75%Xarelto25%Part D≥31 patientsMetabolism & gastrointestinal
5.1%Proton pump inhibitor1.7%Pantoprazole Sodium67%Omeprazole33%Part D<11 patientsPotassium supplement1.7%Potassium Chloride100%Part D≥14 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicting Successful Chronic Total Occlusion Crossing With Primary Antegrade Wiring Using Machine Learning
JACC: Cardiovascular Interventions
2024 - Predictors of Successful Primary Antegrade Wiring in Chronic Total Occlusion Percutaneous Coronary Intervention
The Journal of invasive cardiology/The journal of invasive cardiology
2024 - Comparative Analysis of Polymer Versus Non-Polymer Jacketed Wires in Chronic Total Occlusion Percutaneous Coronary Intervention
The American Journal of Cardiology
2024 - Racial Disparities in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry
The Journal of invasive cardiology/The journal of invasive cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Arthur McCullough, MD
Cleveland Clinic
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”